E
Lithos Group Ltd. LITS
CNSX
Recommendation
Prev Close
$0.10
Volume
--
Avg Vol (90D)
2,269
Market Cap
$649.84K
Dividend & Yield
--
52-Week Range
-- - --
P/E (TTM)
--
EPS (TTM)
-$2.03
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Lite Strategy (NASDAQ:LITS) to Repurchase $25.00 million in Outstanding Stock
10/31/2025 - MarketBeat
Lite Strategy Announces $25M Share Repurchase Program, Signaling Shift From Initial Litecoin ...
10/29/2025 - GuruFocus
Lite Strategy announces $25M share repurchase program
10/29/2025 - The Fly
Lite Strategy Announces $25M Share Repurchase Program, Signaling Shift From Initial Litecoin Accumulation to Active Capital Market Operations
10/29/2025 - Globe Newswire
Lite Strategy (NASDAQ:LITS) Receives Sell (D-) Rating from Weiss Ratings
10/27/2025 - MarketBeat
Lite Strategy Celebrates 14th Anniversary of Litecoin, Taps Institutional Signals Ahead of 2026
10/16/2025 - GuruFocus
Lite Strategy Celebrates 14th Anniversary of Litecoin, Taps Institutional Signals Ahead of 2026
10/16/2025 - Globe Newswire
Video: Monday Sector Laggards: Food, Drugs
10/13/2025 - Market News Video
Lite Strategy's (LITS) Sell (D-) Rating Reiterated at Weiss Ratings
10/10/2025 - MarketBeat
Lite Strategy files to sell 780,497 shares of common stock for holders
10/8/2025 - SeekingAlpha.com: All News
Lite Strategy files to sell 780,497 shares of common stock for holders
10/8/2025 - TipRanks Financial Blog
Lite Strategy files to sell 780,497 shares of common stock for holders
10/8/2025 - The Fly
Wall Street Zen Upgrades Lite Strategy (NASDAQ:LITS) to Hold
10/4/2025 - MarketBeat
Wall Street Zen Downgrades MEI Pharma (NASDAQ:LITS) to Sell
9/21/2025 - MarketBeat
Lite Strategy: From Biotech To Litecoin Treasury
9/16/2025 - Seeking Alpha - Long Ideas
Lite Strategy: From Biotech To Litecoin Treasury
9/16/2025 - SeekingAlpha
Lite Strategy Investor Exercises Warrants in Cashless Deal
9/15/2025 - TipRanks Financial Blog
MEI Pharma, Inc. Rebrands as Lite Strategy, Inc., Adopts New NASDAQ Ticker LITS
9/10/2025 - Business Wire
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
-$534.00K
EBIT (TTM)
-$17.29M
Net Income (TTM)
-$17.22M
Balance Sheet
Total Assets (Q)
$765.80K
Total Debt (Q)
$723.50K
Total Liabilities (Q)
$2.52M
Book Value Per Share (Q)
-$0.193
Cash Flow
Cash from Operations (TTM)
$48.90K
Cash from Investing (TTM)
-$113.00K
Cash from Financing (TTM)
-$97.40K
Net Change in Cash (TTM)
-$173.60K
Filings
Filing Date
Monday, September 29, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Dec 15 and 19 (est)
Price History
Loading...
Beta
-0.41
7-Day Total Return
0.00%
30-Day Total Return
0.00%
60-Day Total Return
-31.03%
90-Day Total Return
-35.48%
Year to Date Total Return
-75.00%
1-Year Total Return
-86.67%
2-Year Total Return
-98.33%
3-Year Total Return
-96.67%
5-Year Total Return
-98.33%
52-week Low
Oct 31, 2025 - --
52-week High
Oct 31, 2025 - --
Valuation
Market Cap
$649.84K - Nano Cap
Enterprise Value
$1.36M
Price/Sales (TTM)
--
Price/Book (Q)
-0.52
Dividends and Shares
Shares Outstanding
9.11
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.lithostechnology.com
Phone Number
877-548-4671
Address
1055 West Hastings Street
Vancouver, BC V6E 2E9
Country
Canada
Year Founded
2010
Business Description
Sector
Materials
Industry
Materials
Lithos Group Ltd. engages in the exploration and development of mineral properties. It holds interest in the Rhodes Marsh property, which consist of two claim blocks located in the Nevada, the... more